Sale!

Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test

Original price was: $300.Current price is: $212.

-29%

The Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test is a specialized diagnostic tool designed to detect drug resistance in Mycobacterium tuberculosis complex strains. This advanced test evaluates susceptibility to five critical second-line antitubercular medications: Ofloxacin, Levofloxacin, Moxifloxacin, PAS, and Cycloserine. Using automated fluorescent technology, this test provides rapid results within 21 days, helping physicians determine the most effective treatment regimen for drug-resistant tuberculosis cases. The test is essential for patients who have failed first-line TB therapy or show resistance patterns. At only $212 USD, this comprehensive panel offers crucial information for managing complex tuberculosis infections and preventing treatment failures.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test

Comprehensive Tuberculosis Drug Resistance Testing

The Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test represents a critical advancement in tuberculosis management, specifically designed to address the growing challenge of drug-resistant TB strains. This sophisticated diagnostic tool utilizes automated fluorescent technology to rapidly assess Mycobacterium tuberculosis complex susceptibility to five essential second-line antitubercular medications. With tuberculosis remaining a significant public health concern globally, this test provides physicians with the precise information needed to develop effective treatment strategies for complex cases.

What This Test Measures and Detects

This specialized panel evaluates bacterial susceptibility to five crucial second-line tuberculosis medications:

  • Ofloxacin – A fluoroquinolone antibiotic effective against many TB strains
  • Levofloxacin – Another fluoroquinolone with broad-spectrum activity
  • Moxifloxacin – A newer generation fluoroquinolone with enhanced potency
  • PAS (Para-aminosalicylic acid) – A traditional second-line TB drug
  • Cycloserine – An important antibiotic for multidrug-resistant TB

The test detects resistance patterns that could compromise treatment effectiveness, allowing for timely adjustments to therapeutic regimens.

Who Should Consider This Test

This advanced tuberculosis testing is recommended for individuals experiencing:

  • Persistent cough lasting more than three weeks
  • Unexplained weight loss and fatigue
  • Night sweats and fever patterns
  • Chest pain and breathing difficulties
  • Previous TB treatment failure
  • Known exposure to drug-resistant TB strains
  • Immunocompromised conditions increasing TB risk
  • Suspected treatment non-compliance issues

Key Benefits of Advanced TB Drug Resistance Testing

  • Personalized Treatment Planning: Enables physicians to create customized treatment regimens based on specific resistance patterns
  • Prevention of Treatment Failure: Identifies drug resistance early to avoid ineffective therapy
  • Reduced Transmission Risk: Helps control drug-resistant TB spread through appropriate treatment
  • Cost-Effective Healthcare: Prevents unnecessary medication expenses and hospitalizations
  • Improved Patient Outcomes: Increases treatment success rates for complex TB cases
  • Public Health Protection: Contributes to better TB control in communities

Understanding Your Test Results

Your test results will provide detailed information about your Mycobacterium tuberculosis strain’s susceptibility to the five second-line drugs tested:

  • Susceptible Results: Indicates the medication is likely to be effective against your TB strain
  • Resistant Results: Shows the medication may not work effectively, requiring alternative treatment options
  • Intermediate Results: Suggests variable effectiveness that may require dosage adjustments

Your physician will interpret these results in the context of your overall health status, previous treatment history, and other clinical factors to develop the most appropriate treatment plan.

Test Pricing Information

Test Name Discount Price Regular Price
Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test $212 USD $300 USD

Nationwide Testing Availability

GGC DNA maintains comprehensive testing facilities across the United States, with branches in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.

Take Control of Your Tuberculosis Treatment Today

Don’t let drug-resistant tuberculosis compromise your health and treatment outcomes. Our Cultured AFB Antitubercular DST Rapid 5 Second Line Drugs Panel Test provides the critical information needed to fight complex TB infections effectively. With rapid 21-day turnaround time and advanced automated fluorescent technology, you can trust GGC DNA for accurate, reliable tuberculosis drug resistance testing.

Ready to schedule your test? Call our dedicated healthcare team at +1(267) 388-9828 or book your appointment online today. Take the first step toward effective tuberculosis management with comprehensive drug resistance testing from GGC DNA.